Koizumi K, Ikeda C, Ito M, Suzuki J, Kinoshita T, Yasukawa K, Hanai T
School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Biomed Chromatogr. 1998 Jul-Aug;12(4):203-10. doi: 10.1002/(SICI)1099-0801(199807/08)12:4<203::AID-BMC736>3.0.CO;2-L.
The influence of glycosylation on the drug binding of human serum albumin (HSA) was studied using HSA containing different amounts and degrees of glycosylated HSA. The drugs used were furosemide, naproxen, procaine, phenylbutazone, salicylic acid, sulphamethoxazole, tolbutamide and warfarin. The drug-HSA parameters (lognK) were measured by the ultrafiltration method, frontal analysis and a modified Hummel-Dreyer method. The modified Hummel-Dreyer method was the simplest method with high precision and required the smallest amounts of proteins. The lognK values were well correlated with the octanol-water partition coefficients; the correlation coefficients were over 0.95. The results suggested that hydrophobic interaction is the predominant force for the drug binding. The early stage of glycosylation of HSA did not significantly affect the drug-binding capacity. Generally, the binding affinity of HSA decreased, perhaps due to a conformational change or steric hindrance (except naproxen) when further glycosylation occurred.
使用含有不同量和不同糖基化程度的人血清白蛋白(HSA),研究了糖基化对HSA药物结合的影响。所使用的药物有呋塞米、萘普生、普鲁卡因、保泰松、水杨酸、磺胺甲恶唑、甲苯磺丁脲和华法林。通过超滤法、前沿分析法和改良的Hummel-Dreyer法测量药物-HSA参数(lognK)。改良的Hummel-Dreyer法是最简单的方法,具有高精度且所需蛋白质的量最少。lognK值与正辛醇-水分配系数具有良好的相关性;相关系数超过0.95。结果表明,疏水相互作用是药物结合的主要作用力。HSA糖基化的早期阶段对药物结合能力没有显著影响。一般来说,当进一步发生糖基化时,HSA的结合亲和力降低,这可能是由于构象变化或空间位阻(萘普生除外)。